Seriously, Why Do Apple Analysts Look So Confused Now?
Apple traded higher after another impressive earnings report. So why is it that investors and analysts have such confusing views on Apple?
Apple traded higher after another impressive earnings report. So why is it that investors and analysts have such confusing views on Apple?
It seems that no company is too big for Carl Icahn to try to influence in an effort to unlock value. AIG is now Icahn's latest public target.
Wednesday's top analyst upgrades, downgrades and initiations include Akamai Technologies, Apple, Devon Energy, GrubHub, JetBlue Airways, Kroger, Twitter, UBS and Yelp.
Some investors love what analysts have to say. Others, not so much. There is just one problem here with this buyout — Rite Aid isn't fetching enough.
RE/MAX has filed a resale shelf registration statement to cover the proposed sale of up to 7.5 million shares.
ThinkstockHow much upside in an analyst call is enough to entice investors? That is a key question that any investor needs to ask when it comes to chasing Wall Street research reports. If it…
ThinkstockWith this week’s FOMC meeting being highly watched, it seems that investors have almost no fears of a rate hike — nor any reason to be elated about a rate hike — perhaps until…
The Wall Street Journal and Dow Jones have reported that Walgreens Boots Alliance is nearing a deal to acquire Rite Aid.
IBM announced on Tuesday that its board of directors has declared a regular quarterly cash dividend and has increased its share buyback authorization.
Marvell Technology is not a stock that most investors expect to see down almost 15% in just one trading session. Unfortunately, Tuesday was no normal trading session.
HCA is out with earnings, but there is a serious question here when it comes to the greater good: should it, or other hospitals, be buying back stock?
Durable goods came in with a negative reading for the month of September and may portend a bad report later this week on GDP.
A pleasant surprise came earlier in October via a consumer sentiment reading from the University of Michigan. But it is not being echoed in the larger consumer confidence reading in October.
Pfizer and Merck both released their third-quarter earnings on Tuesday morning. So, which drug giant is looking better after earnings?
Tuesday's top analyst upgrades, downgrades and initiations include BioDelivery Sciences, Merrimack Pharmaceuticals, Silver Wheaton, Valeant Pharmaceuticals and Weatherford International.
ThinkstockMonday was one of those days with mixed stock market index trading. With the Dow and S&P within about 4% of all-time highs, investors keep proving that they will be opportunistic to buy weakness…
Credit Suisse feels that American Airlines knows what it is doing in discounting to compete with low-cost air carriers.
This week we have the Federal Reserve's Federal Open Market Committee (FOMC) meeting and a gross domestic product (GDP) report due.
Apple supplier Dialog Semiconductor released a preliminary report on its third-quarter interim results Monday.
A new Natixis Global Asset Management report issued this week shows that long-term retirement goals are losing out to short-term financial pressures.